Pfizer Ltd

Pfizer Ltd

Pfizer Ltd has scheduled a board meeting on November 3, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.

Pfizer Ltd

Pfizer Ltd has furnished a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with the regulation for the quarter ended September 30, 2026.

Pfizer Ltd

Pfizer Ltd has announced a special window for re-lodging transfer deeds of physical securities sold/purchased prior to April 1, 2019, in compliance with SEBI's circular dated January 30, 2026.

Pfizer Ltd

Pfizer Ltd has announced the closure of its trading window from September 30, 2026, until 48 hours after the unaudited financial results for the half year ending September 30, 2026, are made public.

Pfizer Ltd

Pfizer Ltd has received an order from the Deputy/Additional Commissioner of Income Tax Transfer Pricing, levying a penalty of Rs. 1,26,34,050/- based on the Transfer Pricing audit conducted for the Assessment Year 2023-24. The company believes that the order is not maintainable and is in the process of preferring an appeal.

Pfizer Ltd

Pfizer Ltd has announced a special window for re-lodgement of transfer and dematerialisation of physical securities, which were sold or purchased prior to April 1, 2019. The window is open from February 5, 2026, to February 4, 2027. Investors can submit their transfer deeds and documents to KFin Technologies Limited, the company's Registrar and Transfer Agent, to enable further processing and transfer of shares, if approved.

Pfizer Ltd

Pfizer Ltd's 75th Annual General Meeting was held on July 28, 2026, with a total of 1,05,890 shareholders on record. The meeting was attended by 46 shareholders through video conferencing, with 63.92% being promoters and 0.04% being public shareholders. The resolutions were passed with requisite majority, with all shareholders voting in favor of the resolutions.

Pfizer Ltd

Pfizer Ltd held its 75th Annual General Meeting on July 28, 2026, through video conferencing. The meeting was chaired by Mr. Pradip Shah, and the requisite quorum was present. The Chairman paid tribute to Late Mr. R.A. Shah, and the Members joined in observing a minute's silence. The proceedings of the meeting were recorded, and the video recording will be made available on the Company's website. The Members were provided the facility of remote e-voting on the resolutions proposed in the Notice of the Annual General Meeting.

Pfizer Ltd

Pfizer Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors at their meeting held on July 28, 2026. The results include a statement of unaudited financial results, which has been reviewed by the statutory auditors, B S R & Co. LLP.

Pfizer Ltd

Pfizer Ltd's Executive Director - Finance & Chief Financial Officer, Mr. Amit Agarwal, has resigned from the services of the company, effective October 8, 2026, to pursue an opportunity outside Pfizer Limited.